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Objective: Several magnetic resonance imaging (MRI) and postmortem studies have supported the role of the thalamus in the patho-
physiology of schizophrenia. Interestingly, a recent small diffusion weighted imaging (DWI) study showed abnormal thalamic microstruc-
ture in patients with schizophrenia. The objective of our study was to use structural MRI and DWI to explore for the first time both thal-
amic volumes and integrity in schizophrenia. Methods: We measured thalamic volumes and apparent diffusion coefficient (ADC)
measures bilaterally in 71 patients with schizophrenia, representative of those living in the geographically defined catchment area of
South Verona (i.e., 100 000 inhabitants), and 75 individuals without schizophrenia. The presence of the adhesio interthalamica was also
detected. Results: We found no significant differences in thalamus size between patients with schizophrenia and participants in the con-
trol group, with only a trend for decreased left volumes. No abnormal frequency of the adhesio interthalamica was found. In contrast, sig-
nificantly increased thalamic ADC values were shown in schizophrenia patients. Age significantly inversely correlated with thalamic vol-
umes in both groups and correlated positively with posterior ADCs in patients with schizophrenia. No significant associations between
clinical variables and either volumes or ADC values were reported. Conclusion: Widespread altered microstructure integrity and partially
preserved thalamus size were found in schizophrenia patients. Therefore, subtle thalamic structural abnormalities are present in schizo-
phrenia, even with maintained volumes. This may result from disruption at the cytoarchitecture level, ultimately supporting corticothal-
amic misconnection. Future imaging studies should further explore thalamic tissue coherence and its role for cognitive disturbances in
patients at high risk for schizophrenia and in first-degree relatives.
Objectif : Plusieurs études fondées sur l’imagerie par résonance magnétique (IRM) et postmortem appuient le rôle du thalamus dans la
pathophysiologie de la schizophrénie. Fait intéressant à souligner, une récente étude d’envergure modeste, fondée sur l’imagerie
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Introduction
Schizophrenia is characterized by impairment of cognitive do-
mains involved in higher cognitive functions such as thought
processing and perception.1 It has been suggested that dys-
functional cortico–subcortical connections are involved in the
pathophysiology and psychopathology of the disease.2,3 In this
regard, the thalamus is a key region for frontotemporal com-
munication and is crucial for modulating emotion and cogni-
tion in humans.4 Indeed, it is a major subcortical relay station
that filters incoming primary sensory input and modulates
processed cortical information through reciprocal corticothal-
amic connections.5 The thalamus is composed of several topo-
graphically organized nuclei, each with precise cortical projec-
tions and function.6,7 In particular, the anterior nuclei are
connected to the limbic regions and play an important role in
memory formation, learning and emotional experience. The
medial group of nuclei project primarily to the prefrontal cor-
tex, and lesions in these nuclei cause deficits in working and
episodic memory. The lateral nuclei participate in higher-
order somatosensory functions, whereas the posterior nuclei
are important in the higher-order visual and auditory func-
tions. Therefore, the thalamus is an important structure in the
relay of sensory and motor information, maintaining con-
sciousness and attention through reciprocal connections with
the cerebral cortex, cerebellum and brain stem.8
The role of the thalamus for the pathophysiology of schizo-
phrenia is supported by imaging and neuropathologic re-
ports. Postmortem studies have reported reductions in neur-
onal and oligodendrocyte numbers in the thalamus of
patients with schizophrenia.9–13 Also, functional neuroim-
aging investigations found thalamic hypoactivation during
cognitive tasks involving working memory, attention and vi-
sual processing in patients with schizophrenia.14–19 Further,
several neurochemical studies using proton magnetic reso-
nance spectroscopy showed decreased thalamic concentra-
tions of N-acetylaspartate, which is a putative marker of
neuronal viability and function,20 in schizophrenia.21–25 More-
over, structural magnetic resonance imaging (sMRI) studies
have found reduced thalamic volumes in schizophrenia.26–32
Conversely, several sMRI studies have found preserved thal-
amic size in schizophrenia.33–37 Although there are some con-
troversial findings for volume abnormalities, these studies
taken together strongly support the role of the thalamus for
the pathophysiology of schizophrenia.4
Interestingly, a recent small diffusion weighted imaging
(DWI) study showed abnormal thalamic microstructure or-
ganization in patients with schizophrenia, particularly in
mediodorsal and anterior nuclei, as shown by increased
mean diffusivity of water.38 By detecting the microscopic mo-
tion of water within the extracellular space, DWI incorpor-
ates diffusion gradient pulses within a conventional MR
pulse sequence, providing important information on tissue
microstructural integrity that cannot be visualized by con-
ventional MRI.39 The apparent diffusion coefficient (ADC)
quantifies water tissue movement, representing a critical
measure for a detailed investigation of brain tissue organiza-
tion and providing evidence of disruption when increased.40
The aim of our study was to combine volume and micro-
structure analysis of the thalamus by using structural MRI
and DWI in a large sample of patients with schizophrenia re-
cruited from the geographically defined catchment area of
South Verona, Italy (i.e., 100 000 inhabitants). Our hypothesis
was that ADC values would be altered in the thalamus of pa-




We recruited 71 patients from the geographically defined
catchment area of South Verona (i.e., 100 000 inhabitants). All
had received a diagnosis of schizophrenia according to the
pondérée en diffusion, a démontré une anomalie de la microstructure du thalamus chez les patients atteints de schizophrénie. Notre
étude avait pour objectif d’utiliser l’IRM et l’imagerie pondérée en diffusion en vue d’explorer pour la première fois les volumes thala-
miques et leur intégrité dans la schizophrénie. Méthodes : Nous avons mesuré les volumes thalamiques et les valeurs du coefficient de
diffusion apparente (CDA) des 2 côtés chez 71 patients atteints de schizophrénie, représentatifs des gens qui vivent dans le secteur
géographiquement défini de la partie sud de Vérone (c.-à-d. 100 000 habitants), et 75 individus non atteints de schizophrénie. La
présence de l’adhérence interthalamique a également été recherchée. Résultats : Nous n’avons pas trouvé de différences significatives
de la taille du thalamus entre les patients atteints de schizophrénie et les participants témoins, si ce n’est une diminution du volume du
thalamus du côté gauche en général. Nous n’avons pas trouvé de fréquence anormale de l’adhérence interthalamique. En revanche, les
valeurs du CDA présentaient une augmentation significative chez les patients atteints de schizophrénie. On a établi une corrélation in-
verse significative entre l’âge et les volumes thalamiques dans les 2 groupes et une corrélation positive avec les CDA postérieurs chez
les patients souffrant de schizophrénie. On n’a signalé aucune association significative entre les variables cliniques et le volume de l’un
ou l’autre côté du thalamus ou encore les valeurs du CDA. Conclusion : On a établi que l’intégrité de la microstructure était nettement al-
térée et que les dimensions du thalamus étaient préservées en partie chez les patients atteints de schizophrénie. On peut donc affirmer
qu’il existe de légères anomalies structurales du thalamus dans la schizophrénie, même si les volumes ne changent pas. Cette situation
s’explique peut-être par une rupture au niveau de la cytoarchitecture, qui expliquerait en bout de ligne un problème de connexion
cortico-thalamique. Dans d’autres études fondées sur l’imagerie, il faudra étudier plus à fond la cohérence du tissu du thalamus et son
rôle dans les problèmes cognitifs chez les patients à haut risque de schizophrénie et chez les personnes apparentées au premier degré.
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criteria of the Diagnostic and Statistical Manual of Mental Disor-
ders, fourth edition (DSM-IV)41 and were being treated by the
South Verona Community-based Mental Health Service and
by other clinics reporting to the South Verona Psychiatric
Care Register42,43 (Table 1). We used the Item Group Checklist
of the Schedules for Clinical Assessment in Neuropsychiatry
(IGC-SCAN)44 to obtain the diagnosis of schizophrenia. This
instrument was administered by research clinical psycholo-
gists who had extensive experience with it. They were re-
quired to show interrater reliability both blindly and in-
dependently with those of a senior investigator also trained
in the instrument by achieving similar diagnoses for at least
8 of 10 assessments. Moreover, we compared the psycho-
pathologic item groups completed by the raters to discuss
any major symptom discrepancies. As well, we regularly en-
sured the reliability of the IGC-SCAN diagnoses by holding
consensus meetings with treating psychiatrists and a senior
investigator. The Italian version of the SCAN was edited by
our group,45 and our investigators attended specific training
courses to learn how to administer the IGC-SCAN. Subse-
quently, diagnoses for schizophrenia according to the DSM-
IV criteria were corroborated with the clinical consensus of
2 staff psychiatrists. We excluded patients with comorbid
psychiatric disorders, epilepsy or other neurologic diseases,
alcohol or substance abuse within the 6 months preceding the
study or a history of traumatic head injury with loss of con-
sciousness. All but 2 patients were receiving antipsychotic
medications at the time of imaging: 24 patients were taking
typical antipsychotic medication (14 haloperidol, 3 chlorpro-
mazine, 2 fluphenazine, 2 clotiapine, 2 zuclopenthixol,
1 thioridazine), and 45 patients were taking atypical anti-
psychotic drugs (25 olanzapine, 10 clozapine, 8 risperidone,
2 quetiapine). We retrieved the patients’ clinical information
from psychiatric interviews, the attending psychiatrist and
medical charts. The Brief Psychiatric Rating Scale (24-item
version)46 was used to characterize clinical symptoms. Again,
it was administered by trained research clinical psychologists
following the same reliability procedure as outlined above
for the IGC-SCAN.
We also recruited 75 individuals without schizophrenia
(control group) (Table 1). They had no DSM-IV axis I disor-
ders, as determined by an interview modified from the Struc-
tured Clinical Interview for DSM-IV nonpatient version
(SCID-NP). As well, they had no history of psychiatric disor-
ders among first-degree relatives, no history of alcohol or
substance abuse and no current major medical illness. They
were recruited from hospital/university staff volunteers or
from individuals undergoing imaging for dizziness whose
MRI showed no evidence of central nervous system abnor-
malities when reviewed by the neuroradiologist (R.C.). Any
dizziness was due to benign paroxysmal positional vertigo or
to nontoxic labyrinthitis. Participants in the control group
were scanned only after a full medical history was taken and
general neurologic, otoscopic and physical examinations were
carried out; they had completely recovered from their dizzi-
ness. Also, none of these participants was taking medication,
including drugs for nausea or vertigo, during the study.
This study was approved by the Biomedical Ethics Com-
mittee of the Azienda Ospedaliera of Verona. All participants
provided signed informed consent after they understood all
aspects of study participation.
MRI procedure
MRI scans were acquired with a 1.5 T Magnetom Symphony
Maestro class syngo MR 2002B (Siemens), and in total, it took
about 19 minutes to complete an MR session. A standard head
coil was used for radio frequency transmission and reception
of the MR signal, and restraining foam pads were used to mini-
mize head motion. T1-weighted images were first obtained to
verify the participant’s head position and image quality
(TR = 450 ms, TE = 14 ms, flip angle = 90°, FOV = 230 × 230,
18 slices, slice thickness = 5 mm, matrix size = 384 × 512,
NEX = 2). Proton density (PD)/T2–weighted images were then
acquired (TR = 2500 ms, TE = 24/121 ms, flip angle = 180°,
FOV = 230 × 230, 20 slices, slice thickness = 5 mm, matrix
size = 410 × 512, NEX = 2) according to an axial plane running
parallel to the anterior–posterior (AC–PC) commissures to ex-
clude focal lesions. Subsequently, a coronal 3-dimensional
magnetization prepared rapid gradient echo (MP-RAGE) 
sequence was acquired (TR = 2060 ms, TE = 3.9 ms, flip
angle = 15°, FOV = 176 × 235, slice thickness = 1.25 mm, matrix
size = 270 × 512, inversion time = 1100) to obtain 144 images
covering the entire brain. Diffusion weighted echo-planar
images were acquired in the axial plane parallel to the AC–PC
line (TR = 3200 ms, TE = 94 ms, FOV = 230 × 230, 20 slices, slice
thickness = 5 mm with 1.5 mm gap, matrix size = 128 × 128,
echo train length = 5; these parameters were the same for b = 0,
b = 1000, and the ADC maps). Specifically, 3 gradients were ac-
quired in 3 orthogonal directions.
Anatomical image analysis
Anatomical imaging data were transferred to a PC work-
Table 1: Characteristics of the study groups





(n = 71) Test df p




t = 0.40 144 0.69
Male/female 39/36 46/25 χ2 = 0.78 1 0.34
Right-handed/
left-handed
61/14 59/12 χ2 = 0.16 1 0.69
Ethnicity European European
Age at onset, yr 26.43 (9.29)
Duration of illness, yr 13.92 (10.79)











BPRS = Brief Psychiatric Rating Scale; SD = standard deviation.
*Unless otherwise indicated.
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station and analyzed with the BRAINS2 software developed
at the University of Iowa. After the thalamus was identified
in the coronal plane, its limits were manually traced.47,48 All
thalamic measurements were done by a well-trained rater
(O.K.) blinded to the participant’s identity. Interrater reliabil-
ity of r = 0.96  for the right thalamus and r = 0.95 for the left
thalamus was achieved. Thalamic volumes (mL) were ob-
tained by summing the volumes of all relevant slices and
were expressed in cubic centimetres.
The tracing of the thalamus was performed on the 
T1-weighted MP-RAGE sequence, beginning at the coronal
slice where the anterior pillars of the fornix merge into the
mammillary bodies and continuing to the slice in which it
was no longer possible to distinguish the thalamus from the
surrounding brain matter. The lateral ventricles at the superi-
or border, the red nucleus and the substantia nigra at the in-
ferior border, the posterior limb of the internal capsule at the
lateral border separating the thalamus from the adjacent
lentiform nucleus and the third ventricle at the medial border
demarcated the limits of the thalamus (Fig. 1). The presence
of the adhesio interthalamica was also detected.
Intracranial volume (ICV) was traced in the coronal plane
along the border of the brain and included the cerebrospinal
fluid (CSF), dura mater, sinus, optic chiasma, brainstem, cere-
bral and cerebellar matter. The inferior border did not extend
below the base of the cerebellum. The first and last 10 slices
including brain matter were traced, after which 1 of every
5 slices was traced. ICV measurements were obtained by a
well-trained rater who achieved interrater reliability of 0.97
(intraclass correlation coefficient), established by blindly
tracing 10 randomly selected scans.
Diffusion image analysis
Images were displayed on a commercial Siemens work-
station for the postprocessing analyses, including the calcula-
tion of ADC values. ADC maps were obtained from the dif-
fusion images, with b = 1000, according to the following
equation: –bADC = ln [A(b)/A(0)], where A(b) is the meas-
ured echo magnitude, b is the measure of diffusion weighting
and A(0) is the echo magnitude without diffusion gradient
applied.49 The resulting ADC was expressed in units of 
10−5 mm2/s. Circular regions of interest (ROIs) standardized
at 5 pixels (corresponding to an area of 0.16 cm2) were placed
on both the right and left thalamus in 4 subregions (i.e., an-
terior, centromedial, centrolateral and posterior) on the
non–diffusion weighted (b = 0) echoplanar images (Fig. 2).
One axial slice at the level of the anterior and posterior horns
of the lateral ventricles was chosen, and adjacent slices were
checked to ensure that partial volume effects from CSF were
minimized. The anterior, centromedial and posterior ROIs
were placed following the medial limits of the thalamus, and
the centrolateral ROI was placed close to the lateral border in
front of the centromedial ROI. The 4 resulting thalamic sub-
regions approximately corresponded to anatomical subdiv-
isions of the thalamus (i.e., the anterior ROI to the anterior
Fig. 1: Anatomical landmarks of the thalamus for detection of volume. The tracing of the thalamus
began at the coronal slice where the anterior pillars of the fornix merge into the mammillary bodies
and continued to the slice in which it was no longer possible to distinguish the thalamus from the sur-
rounding brain matter.
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nuclei, the centromedial ROI to the dorsomedial nucleus, the
centrolateral ROI to the ventrolateral nuclei and the posterior
ROI to the pulvinar). The ROIs were then automatically
transferred to the corresponding maps to obtain the ADC of
water molecules. Two raters achieved high reliability, as de-
fined by intraclass correlation coefficients over 0.85, estab-
lished by tracing 8 training scans. Then, the same rater, blind
to study hypotheses, group assignment and socio-
demographic/clinical data, measured all scans.
Statistical analyses
All analyses were conducted with the SPSS for Windows
software, version 11.0 (SPSS, Inc.); we set the 2-tailed statis-
tical significance level at p < 0.05. We used a multivariate
analysis of covariance (MANCOVA) to compare volumes
and ADC values between patients with schizophrenia and
participants in the control group, and we used Bonferroni ad-
justment  for multiple comparisons. The assumption that the
vector of the measures followed a multivariate normal distri-
bution (Kolmogorov–Smirnov test) and the variance-
covariance matrices for all cells were the same (Box M test)
was verified. Pearson correlation and partial correlation
analyses controlled for age were used to examine possible as-
sociations between age and clinical variables, respectively,
and thalamic measures.
Results
Volumes and ADC measures
The assumptions for the MANCOVA were verified for both
volumes and ADC values. Thalamic size slightly differed be-
tween patients with schizophrenia and individuals without
schizophrenia (MANCOVA with age, sex and ICV as covari-
ates; p = 0.053), with trends for significantly decreased vol-
umes in the left side (Table 2). In both patients and partici-
pants in the control group, the right thalamus was larger
than the left, this difference being statistically significant (Stu-
dent paired t test, t70 = 3.18, p < 0.01; t74 = 2.35, p = 0.02, re-
spectively). Accordingly, we found no significant group dif-
ferences for the right-to-left volume difference (volumes of
right minus left thalamus) and the laterality index (right mi-
nus left volumes, divided by the sum of right and left vol-
umes) (MANCOVA with age and sex as covariates; p > 0.05).
The adhesio interthalamica was absent in 2 of 75 individuals
without schizophrenia (2.67%) and in 6 out of 71 patients
with schizophrenia (8.45%), the between-group difference
being nonsignificant (χ21 = 2.36, p = 0.12).
In contrast, patients with schizophrenia had significantly
greater ADC values when compared with participants in the
control group over all thalamic subregions (MANCOVA
with age and sex as covariates; p = 0.03) (Table 2). After
Bonferroni adjustment for multiple comparisons, right ante-
rior, right centromedial, right posterior and left centrolateral
ADC values were still significantly greater among patients
when compared with participants in the control group
Fig. 2: Regions of interest (ROIs) placed in the thalamus for detec-
tion of the apparent diffusion coefficient (ADC). ROIs were placed in
an axial slice at the level of the anterior and posterior horns of the
lateral ventricles by following the medial limits of the thalamus for
the anterior, centromedial and posterior ROIs. The centrolateral ROI
was placed at the lateral border in front of the centromedial ROI.
Table 2: Volume and ADC measures for the thalamus in participants
in the control group and in patients with schizophrenia
Group; mean (and SD) Statistics*
Thalamus
measures Control (n = 75)
Schizophrenia




Left 4.76 (0.52) 4.63 (0.62) 3.82 0.05




Right 72.72 (4.22) 75.50 (5.81) 10.49 0.001
Left 71.59 (5.17) 73.28 (5.65) 4.34 0.03
Centromedial
Right 73.23 (3.61) 75.74 (5.30) 12.12 < 0.001
Left 72.97 (4.18) 74.75 (5.44) 5.18 0.02
Centrolateral
Right 69.36 (3.87) 71.52 (5.62) 6.86 0.009
Left 67.98 (4.87) 70.28 (5.64) 7.55 0.006
Posterior
Right 73.10 (3.82) 75.78 (5.20) 13.78 < 0.001
Left 74.31 (4.48) 76.21 (4.92) 6.68 0.01
ADC = apparent diffusion coefficient; SD = standard deviation.
*Multivariate analysis of covariance was performed to compare thalamic volumes (with
age, sex and intracranial volume as covariates, F = 3.01, p = 0.053) or ADC values
(with age and sex as covariates, F = 2.19, p = 0.03) between patients with
schizophrenia and normal control subjects. The statistics for the univariate analysis of
covariance are reported for both volumes (d1/141) and ADC values (d1/142).
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(p = 0.012, p = 0.005, p = 0.002 and p = 0.05, respectively), with
trends for significantly greater measures for right centrolat-
eral and left posterior (p = 0.08 and p = 0.09, respectively). Af-
ter Bonferroni adjustment, no significant differences were
found for left anterior and left centromedial ADCs (p = 0.31
and p = 0.19, respectively).
When the 2 groups were stratified by sex, male patients
had significantly greater ADC values in comparison with
men in the control group (p < 0.05), with the exception of left
anterior ADC values (p = 0.09); whereas female patients with
schizophrenia had significantly greater ADC values for the
right (p < 0.05) but not the left side (p > 0.05) compared with
women in the control group (Student t test).
We also had similar findings when we separately com-
pared schizophrenia patients with participants in the control
group from hospital/university staff (n = 38) or with re-
covered dizziness (n = 37): in patients with schizophrenia,
thalamic volumes were preserved and ADC measures
increased. Moreover, we found no significant differences
between the 2 subgroups of the control group for any thal-
amic values — either volumes (MANCOVA with age, sex
and ICV as covariates; p = 0.86) or ADC measures
(MANCOVA with age and sex as covariates; p = 0.21).
Age effects
We found significant inverse correlations between left and
right thalamic volumes and age in both the control group
(Pearson correlation coefficient = –0.37, p = 0.002; Pearson
correlation coefficient = –0.40, p < 0.001, respectively) and pa-
tients with schizophrenia (Pearson correlation coeffi-
cient = –0.45, p < 0.001; Pearson correlation coefficient = –0.55,
p < 0.001, respectively). Also, left and right posterior thalamic
ADC values were positively associated with age in patients
(Pearson correlation coefficient = 0.32, p = 0.007; Pearson cor-
relation coefficient = 0.36, p = 0.002, respectively) but not in
individuals without schizophrenia (Pearson correlation co-
efficient = 0.11, p = 0.39; Pearson correlation coefficient = 0.21,
p = 0.09, respectively). All other thalamic ADC values did not
significantly correlate with age in either group (Pearson’s cor-
relation coefficient, p > 0.05).
Clinical variables
No significant associations were reported between clinical
variables (age at onset, length of illness, number of prior
hospitalizations, Brief Psychiatric Rating Scale scores, anti-
psychotic lifetime treatment) and thalamic volumes or
ADCs (partial correlation controlled for age, p > 0.05).
Compared with the control group, patients treated with
either typical (n = 24) or atypical (n = 45) antipsychotic
drugs had significantly greater ADC measures
(MANCOVA with age and sex as covariates, p < 0.05),
whereas they did not significantly differ for volumes
(MANCOVA with age, sex and ICV as covariates, p > 0.05).
We found no significant differences between patients on
typical and atypical antipsychotics for either volumes or
ADC measures (MANCOVA, p > 0.05).
Discussion
To the best of our knowledge, this is the first study combin-
ing the analyses of thalamic volumes and microstructural or-
ganization in schizophrenia and reporting widespread al-
tered integrity, as shown by increased ADC values. On the
contrary, partially preserved thalamic volumes, at least in the
right side, and a normal pattern of right-greater-than-left
asymmetry were found in patients with schizophrenia.
Nonetheless, a trend for significantly decreased left thalamic
volumes was shown, which may become significant with a
larger sample. A recent study also showed abnormally in-
creased water diffusivity within the thalamus in 12 patients
with schizophrenia, particularly in mediodorsal and anterior
nuclei.38 Consistent with our findings, preserved thalamic
volumes were found in several prior MRI reports.50 More-
over, a review showed that only 42% of all MRI studies pub-
lished from 1988 to 2001 found strong-to-moderate evidence
of thalamic volume reduction in schizophrenia.51 These con-
flicting findings on thalamic volumes in schizophrenia may
be due to heterogeneous patient populations and different
methods of analysis. However, this study suggests that subtle
changes in thalamic tissue composition in schizophrenia may
not necessarily affect the structural gross volume and should
be investigated at a cytoarchitecture level. In this regard, the
DWI technique is instrumental. Indeed, it provides evidence
of tissue disruption even when conventional volumetric
quantification fails to detect size differences between patients
and individuals without schizophrenia.52 Specifically, the
ADC maps provide a relative representation of the diffusion
coefficient in each pixel within the image, where low- and
high-intensity values indicate, respectively, low and high
microscopic water diffusion.49 In particular, increased ADC
values reflect disruption of the composition of the extracellu-
lar interneuronal space, which may ultimately lead to altered
neuronal and glial cross-talk mediated by neurotransmitters.
It has been strongly suggested that abnormalities of neuro-
transmission systems, such as the dopamine, glutamate or 
γ-aminobutyric acidergic systems, are the core of the patho-
physiology of schizophrenia. Potentially, alterations of thala-
mic microstructure organization may sustain such cellular
communication deficits in schizophrenia in the context of the
corticothalamic misconnection theory.53,54 This may ultimately
result in impaired thalamic function and biochemical integrity,
as shown by recent functional MRI and proton magnetic reso-
nance spectroscopy studies.50
Interestingly, a significant inverse correlation between age
and thalamic volumes bilaterally was found in this study for
both patients and individuals without schizophrenia, sug-
gesting a shrinkage of thalamic size with aging. Also, a nega-
tive effect of age on the integrity of the posterior thalamic
subregion was shown in patients with schizophrenia, but not
in participants in the control group. In our method, this area
largely corresponds to the pulvinar nucleus, which is an as-
sociation nucleus with reciprocal projections with the pre-
frontal, superior temporal and parietooccipital cortices.55,56 It
participates in modulating cortical signal processing, specific-
ally, visual and auditory attention.57 In this regard, pulvino-
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cortical disconnections have been proposed to support visual
attentional deficits in schizophrenia.58 Volume reductions and
metabolic alterations of the pulvinar nucleus have also been
reported in patients with schizophrenia,59–61 particularly in
those with more severe disease.62,63 Thus the pulvinar is a key
thalamic region for the pathophysiology of schizophrenia,
and an aging effect on its microstructure, as suggested by this
study, may contribute to compromising cortico–pulvinar–
cortical connections in patients with schizophrenia.64,65
The adhesio interthalamica is a thin midline structure con-
necting the 2 thalami and containing several nuclei involved
in attention. It has been suggested that the absence of this
structure is a marker of early neurodevelopmental changes in
schizophrenia. In our study, it was absent in about 3% of par-
ticipants in the control group and in about 9% of patients;
however, this difference was not statistically significant. At
least 6 prior MRI studies evaluated the prevalence of absent
adhesio interthalamica in schizophrenia patients, reporting
both positive66–68 and negative findings.28,69,70 In particular, ab-
sence of adhesio interthalamica was more common in first-
episode patients when compared with the control group.68
Another study observed the lack of adhesio interthalamica in
almost 11% of participants in the control group and in 18% of
schizophrenia patients69 without, however, finding any statis-
tically significant group differences. Further, a recent twin
study did not observe any abnormal frequency of the adhesio
interthalamica in schizophrenia.28 Our findings are in line
with prior negative investigations showing that the preva-
lence of absent adhesio interthalamica, although often more
frequent in patients with schizophrenia, did not significantly
differ in comparison with the control group. Therefore, the
literature only in part sustains the role of the absence of ad-
hesio interthalamica for the pathophysiology of the disease,
which may be relevant for the neurodevelopment of particu-
lar subgroups, such as female schizophrenia patients67 or pa-
tients with more severe negative symptoms.70
Limitations
This study has some limitations that should be considered.
First, our sample largely comprised patients treated over the
long-term. Thus whether thalamic disruption preceded the
onset of the illness or appeared subsequently as a result of ill-
ness course or psychotropic treatment cannot be elucidated.
However, clinical variables, including length of illness and
antipsychotic lifetime administration, did not significantly af-
fect ADC values, suggesting that disruption of thalamic in-
tegrity is independent of illness severity, chronicity or medica-
tion. Also, we recruited a larger number of patients who were
well matched to participants in the control group, providing
adequate power. Second, part of our control group was se-
lected from persons undergoing MR scanning for dizziness,
which may represent a methodological limitation. However,
they were fully recovered at the time of imaging and had no
evidence of central nervous system abnormalities on their
scans; auditory evoked potentials were not investigated in
these individuals. Third, no specific thalamic nuclei were in-
vestigated; therefore, we cannot exclude the possibility that
volumes of particular subnuclei may actually differ between
patients and the control group. Finally, the ROI positioning for
detecting ADC values was based on a geometric anatomical
division of the thalamus that only partially corresponds to
thalamic nuclei. Finally, as a possible strength, it should be
noted that our DWI protocol was short and clinically feasible
in the real world of psychiatric practice. It could potentially be
added to any conventional scan session as a complementary
method for the evaluation of microstructure organization not
detectable by sMRI. This would represent a clinical and scien-
tific advantage, according to the evidence for impaired thal-
amic and white matter communication in patients with
schizophrenia.71–73
In conclusion, this study found widespread disrupted thal-
amic cytoarchitecture in the presence of preserved volumes
in a large sample of patients with schizophrenia who were
representative of those living in the geographically defined
catchment area of South Verona (i.e., 100 000 inhabitants).
Abnormalities of thalamic microstructure in schizophrenia
may represent bizarre organization at the cellular level, re-
sulting in perturbation of corticothalamic connectivity and
being relevant for the cognitive disturbances reported in pa-
tients with this disorder. Future diffusion imaging studies
should further explore thalamic coherence in patients at high
risk for schizophrenia and in first-degree relatives.
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